Checklist: consent and redisclosure of substance use disorder records under the 2024 Part 2 rule

Thirteen steps for Part 2 programs and the providers, plans and other lawful holders that receive their records, on the consent form, the notice that travels with each disclosure, and what recipients may do next, under rules with a compliance date of February 16, 2026.

What changed and when

HHS published the final rule on the Confidentiality of Substance Use Disorder (SUD) Patient Records at 89 FR 12472 on February 16, 2024. It took effect on April 16, 2024, and persons subject to it had to comply with the applicable requirements by February 16, 2026 [2]. The rule lets a patient give a single consent for all future uses and disclosures for treatment, payment and health care operations, and lets covered entities and business associates that receive records under that consent redisclose them as the HIPAA rules allow, except in proceedings against the patient [1].

One provision is not yet in force: HHS tolled the effective and compliance dates of the accounting of disclosures section, 2.25, until it revises the HIPAA accounting provision at 45 CFR 164.528 [2]. That section is left out of the steps below.

Using the steps

The first eight steps concern the Part 2 program that obtains consent and discloses; the rest concern what recipients may and may not do. Each cites the section of 42 CFR part 2 it rests on, as current on eCFR to November 12, 2026 [1]. Where a step is our suggestion, it says so. The owner under each step is a typical role, not one the rule names, unless the step says the rule names it. This page explains the rule; it is not legal advice, and state law may add its own limits.

Moraph’s teams help organizations with work like this. See our solutions.

The checklist

Tick the steps as you go. The ticks are kept in this browser only; nothing is sent to us.

  1. Privacy officer with legal

    Section 2.11 defines a Part 2 program as a federally assisted program, an intermediary as a person other than a Part 2 program, covered entity or business associate that receives records under a general designation for its member participants, and a lawful holder as anyone bound by Part 2 because it received records under a consent with the required notice or under an exception [1]. Section 2.12 sets which records are covered [1]. The duties in the steps below differ by role.

  2. Privacy officer

    Section 2.31(a)(1) to (9) requires the patient’s name; who may make the use or disclosure; a specific and meaningful description of the information; the recipients; each purpose; the right to revoke in writing and how; an expiration date or event; the signature, including a person authorized under sections 2.14 or 2.15 where required; and the date signed. Electronic signatures are allowed where other law does not prohibit them [1].

  3. Privacy officer with patient access staff

    Section 2.31(a)(4)(i) allows recipients to be described as “my treating providers, health plans, third-party payers, and people helping to operate this program” or similar; section 2.31(a)(5)(ii) accepts “for treatment, payment, and health care operations” as the purpose; and section 2.31(a)(7) accepts “end of the treatment,” “none” or similar as the expiration [1].

  4. Privacy officer

    Section 2.31(a)(10) requires statements on the potential for redisclosure by the recipient, after which the records are no longer protected by Part 2, and on the consequences of refusing to sign. Section 2.31(a)(4)(iii) requires a statement that a covered entity or business associate recipient may redisclose under HIPAA, except for proceedings against the patient. Section 2.31(a)(5)(iii) requires a statement of the right to opt out of fundraising if the program will fundraise [1].

  5. Privacy officer with clinical leadership

    Section 2.31(b) requires consent for most uses and disclosures of SUD counseling notes, allows that consent to be combined only with another counseling notes consent, and bars conditioning treatment, payment, enrollment or eligibility on it. Section 2.31(d) bars combining consent for use in civil, criminal, administrative or legislative proceedings with any other consent [1].

  6. Health information exchange or interoperability lead

    Section 2.31(a)(4)(ii) sets the consent wording for intermediaries. Under section 2.24, when a patient consented through a general designation, the intermediary must answer the patient’s written request, limited to the past 3 years, within 30 days, giving for each disclosure the recipient, the date and a brief description of the information [1].

  7. Health information management or release of information staff

    Section 2.31(c) bars disclosure on a consent that has expired, substantially fails to conform to section 2.31(a) on its face, is known to have been revoked, or is known, or through reasonable diligence could be known, to be materially false [1]. Under section 2.33(a)(2), a single treatment, payment and operations consent lasts until the patient revokes it in writing [1].

  8. Health information management

    Section 2.32(a) requires one of two statements: the longer Statement 1 or Statement 2, “42 CFR part 2 prohibits unauthorized use or disclosure of these records.” Section 2.32(b) requires a copy of the consent or a clear explanation of its scope [1]. Building both into electronic exchange as well as paper releases is our suggestion.

  9. Privacy officer of the receiving organization

    Section 2.33(b)(1) allows such recipients to redisclose under the HIPAA regulations, except for uses and disclosures in civil, criminal, administrative and legislative proceedings against the patient. Section 2.12(d)(2)(i)(C) says a Part 2 program, covered entity or business associate receiving records under that consent is not required to segregate or segment them [1].

  10. Legal with release of information staff

    Section 2.12(d)(1) applies this restriction to anyone who obtains the records from a Part 2 program, covered entity, business associate, intermediary or other lawful holder, whatever their status. It bars use as evidence, in agency decisions, for law enforcement investigations and in warrant applications [1]. Flagging received Part 2 records in the record system so that legal requests are routed for review is our suggestion.

  11. Legal and procurement

    Sections 2.33(b)(3) and 2.33(c) allow such redisclosure only as necessary for the payment or operations named in the consent, under a written contract binding the recipient to Part 2. The lawful holder must give the section 2.32 notice, require safeguards and reporting of unauthorized uses, disclosures or breaches, and share only what the contractor needs [1].

  12. Patient access and privacy officer

    Section 2.26(a) requires a Part 2 program to let patients request restrictions even after signing consent. It need not agree to most requests, but must agree to restrict disclosure to a health plan for payment or operations, not otherwise required by law, when the record concerns only an item or service paid in full by the patient or someone other than the plan [1].

  13. Privacy officer

    Section 2.4(a) requires a Part 2 program to provide a process to receive complaints, and section 2.4(b) allows any person to complain to the Secretary about a Part 2 program, covered entity, business associate, qualified service organization or lawful holder [1].

Spotted an error? Tell us and we will check it and correct the checklist where needed.

  • 42 CFR part 2
  • HHS
  • substance use disorder records
  • consent
  • redisclosure
  • HIPAA
  • health information exchange